Cargando…

Advanced Glycation End Products in the Skin: Molecular Mechanisms, Methods of Measurement, and Inhibitory Pathways

Advanced glycation end products (AGEs) are a series of stable compounds produced under non-enzymatic conditions by the amino groups of biomacromolecules and the free carbonyl groups of glucose or other reducing sugars commonly produced by thermally processed foods. AGEs can cause various diseases, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chun-yu, Zhang, Jia-Qi, Li, Li, Guo, Miao-miao, He, Yi-fan, Dong, Yin-mao, Meng, Hong, Yi, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131003/
https://www.ncbi.nlm.nih.gov/pubmed/35646963
http://dx.doi.org/10.3389/fmed.2022.837222
_version_ 1784713093602869248
author Chen, Chun-yu
Zhang, Jia-Qi
Li, Li
Guo, Miao-miao
He, Yi-fan
Dong, Yin-mao
Meng, Hong
Yi, Fan
author_facet Chen, Chun-yu
Zhang, Jia-Qi
Li, Li
Guo, Miao-miao
He, Yi-fan
Dong, Yin-mao
Meng, Hong
Yi, Fan
author_sort Chen, Chun-yu
collection PubMed
description Advanced glycation end products (AGEs) are a series of stable compounds produced under non-enzymatic conditions by the amino groups of biomacromolecules and the free carbonyl groups of glucose or other reducing sugars commonly produced by thermally processed foods. AGEs can cause various diseases, such as diabetes, atherosclerosis, neurodegeneration, and chronic kidney disease, by triggering the receptors of AGE (RAGEs) in the human body. There is evidence that AGEs can also affect the different structures and physiological functions of the skin. However, the mechanism is complicated and cumbersome and causes various harms to the skin. This article aims to identify and summarise the formation and characteristics of AGEs, focussing on the molecular mechanisms by which AGEs affect the composition and structure of normal skin substances at different skin layers and induce skin issues. We also discuss prevention and inhibition pathways, provide a systematic and comprehensive method for measuring the content of AGEs in human skin, and summarise and analyse their advantages and disadvantages. This work can help researchers acquire a deeper understanding of the relationship between AGEs and the skin and provides a basis for the development of effective ingredients that inhibit glycation.
format Online
Article
Text
id pubmed-9131003
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91310032022-05-26 Advanced Glycation End Products in the Skin: Molecular Mechanisms, Methods of Measurement, and Inhibitory Pathways Chen, Chun-yu Zhang, Jia-Qi Li, Li Guo, Miao-miao He, Yi-fan Dong, Yin-mao Meng, Hong Yi, Fan Front Med (Lausanne) Medicine Advanced glycation end products (AGEs) are a series of stable compounds produced under non-enzymatic conditions by the amino groups of biomacromolecules and the free carbonyl groups of glucose or other reducing sugars commonly produced by thermally processed foods. AGEs can cause various diseases, such as diabetes, atherosclerosis, neurodegeneration, and chronic kidney disease, by triggering the receptors of AGE (RAGEs) in the human body. There is evidence that AGEs can also affect the different structures and physiological functions of the skin. However, the mechanism is complicated and cumbersome and causes various harms to the skin. This article aims to identify and summarise the formation and characteristics of AGEs, focussing on the molecular mechanisms by which AGEs affect the composition and structure of normal skin substances at different skin layers and induce skin issues. We also discuss prevention and inhibition pathways, provide a systematic and comprehensive method for measuring the content of AGEs in human skin, and summarise and analyse their advantages and disadvantages. This work can help researchers acquire a deeper understanding of the relationship between AGEs and the skin and provides a basis for the development of effective ingredients that inhibit glycation. Frontiers Media S.A. 2022-05-11 /pmc/articles/PMC9131003/ /pubmed/35646963 http://dx.doi.org/10.3389/fmed.2022.837222 Text en Copyright © 2022 Chen, Zhang, Li, Guo, He, Dong, Meng and Yi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Chen, Chun-yu
Zhang, Jia-Qi
Li, Li
Guo, Miao-miao
He, Yi-fan
Dong, Yin-mao
Meng, Hong
Yi, Fan
Advanced Glycation End Products in the Skin: Molecular Mechanisms, Methods of Measurement, and Inhibitory Pathways
title Advanced Glycation End Products in the Skin: Molecular Mechanisms, Methods of Measurement, and Inhibitory Pathways
title_full Advanced Glycation End Products in the Skin: Molecular Mechanisms, Methods of Measurement, and Inhibitory Pathways
title_fullStr Advanced Glycation End Products in the Skin: Molecular Mechanisms, Methods of Measurement, and Inhibitory Pathways
title_full_unstemmed Advanced Glycation End Products in the Skin: Molecular Mechanisms, Methods of Measurement, and Inhibitory Pathways
title_short Advanced Glycation End Products in the Skin: Molecular Mechanisms, Methods of Measurement, and Inhibitory Pathways
title_sort advanced glycation end products in the skin: molecular mechanisms, methods of measurement, and inhibitory pathways
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131003/
https://www.ncbi.nlm.nih.gov/pubmed/35646963
http://dx.doi.org/10.3389/fmed.2022.837222
work_keys_str_mv AT chenchunyu advancedglycationendproductsintheskinmolecularmechanismsmethodsofmeasurementandinhibitorypathways
AT zhangjiaqi advancedglycationendproductsintheskinmolecularmechanismsmethodsofmeasurementandinhibitorypathways
AT lili advancedglycationendproductsintheskinmolecularmechanismsmethodsofmeasurementandinhibitorypathways
AT guomiaomiao advancedglycationendproductsintheskinmolecularmechanismsmethodsofmeasurementandinhibitorypathways
AT heyifan advancedglycationendproductsintheskinmolecularmechanismsmethodsofmeasurementandinhibitorypathways
AT dongyinmao advancedglycationendproductsintheskinmolecularmechanismsmethodsofmeasurementandinhibitorypathways
AT menghong advancedglycationendproductsintheskinmolecularmechanismsmethodsofmeasurementandinhibitorypathways
AT yifan advancedglycationendproductsintheskinmolecularmechanismsmethodsofmeasurementandinhibitorypathways